Skip to main content

Cristina Hernández Pascual

Institutions of which they are part

Main researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Cristina Hernández Pascual

Institutions of which they are part

Main researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR) Grant Agreement nº 278040

IP: Rafael Simó Canonge
Collaborators: Cristina Hernández Pascual
Funding agency: EUROPEAN COMMISSION
Funding: 936725.31
Reference: EUROCONDOR_FP7HEALTH2011/VHIR
Duration: 01/03/2012 - 30/06/2016

Neurodegeneration as an early event in the pathogenesis of diabetic netinopathy. Study of involved mechanisms and new therapeutic strategies

IP: Rafael Simó Canonge
Collaborators: Cristina Hernández Pascual, Patricia Bogdanov Baruj
Funding agency: European Foundation for the Study of Diabetes
Funding: 100000
Reference: EFSD-2010-02
Duration: 28/10/2010 - 27/04/2012

Grup de Recerca en Diabetis i Metabolisme

IP: Rafael Simó Canonge
Collaborators: Carles Zafon Llopis, Cristina Hernández Pascual, David Martinez Selva, Andreea Ciudin Mihai
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 43680
Reference: 2009 SGR 739
Duration: 01/01/2010 - 30/04/2014

Sex hormone-binding globulin (SHBG): Identification of the molecular mechanisms that regulate its expression and role in body fat distribution and in the development of type 2 diabetes

IP: David Martinez Selva
Collaborators: Rafael Simó Canonge, Cristina Hernández Pascual, Albert Lecube Torelló
Funding agency: Instituto de Salud Carlos III
Funding: 42000
Reference: CP08/00058
Duration: 01/01/2009 - 31/12/2011

Related news

The families of the professionals had the opportunity to visit the facilities and discover how we work at the institution.

The document provides recommendations for identifying people who are candidates for these treatments and for guiding their implementation and follow-up in clinical practice.

The publications update the pharmacological management guideline for obesity and its complications and present the first European comprehensive management guideline for patients with obesity treated with medications.

Related professionals

Victor  Barro  Ojeda

Victor Barro Ojeda

Predoctoral researcher
Reconstructive Surgery of the Locomotor System
Read more
Sandra Castro Boix

Sandra Castro Boix

Predoctoral researcher
General Surgery
Read more
Rosa Burgos Peláez

Rosa Burgos Peláez

Research technician
Diabetes and Metabolism
Read more
Ramon Martí Seves

Ramon Martí Seves

Head of group
Neuromuscular and Mitochondrial Pathology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.